๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Nicotine-produced heamodynamic changes in patients with ischaemia of lower limb

โœ Scribed by G. S. Makin


Publisher
John Wiley and Sons
Year
1968
Tongue
English
Weight
277 KB
Volume
55
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

โœฆ Synopsis


IT is generally assumed that cigarette smoking has a deleterious effect on blood-flow in the ischaemic limb, and patients whose limbs are so afflicted are usually advised to stop smoking. However, no objective evidence is available to support such an assumption.

The early work on the influence of nicotine on cutaneous blood-flow has been reviewed by Rottenstein, Pierce, RUSS, Felder, and Montgomery (1960). These workers studied the changes in muscle bloodflow produced by nicotine in normal subjects and found that it was increased. Further examination of their data shows a concomitant fall in resistance.

Work on nicotine-induced changes in blood-flow in ischaemic limbs is scanty. Maddock and Coller (1937) studied I patient with a 'peripheral vascular disturbance'. Coffman and Javett (1963) included in their series 6 patients with atherosclerosis and found no change in total blood-flow through the limb after cigarette smoking.

The following investigation was planned to study the acute effects of an intravenous injection of nicotine-the vaso-active component of cigarette smoke-on blood-flow in the muscles of the ischaemic limb. Smoking itself was not studied because it requires deep breathing and this causes circulatory changes (Abramson and Ferris, 1940).


๐Ÿ“œ SIMILAR VOLUMES


Evaluation of oral thymoxamine in patien
โœ Margaret Thomas; H. Campbell; G. E. Heard ๐Ÿ“‚ Article ๐Ÿ“… 1973 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 337 KB ๐Ÿ‘ 1 views

## Abstract To determine the effectiveness of oral thymoxamine (Opilon) as a cutaneous vasodilator in patients with peripheral vascular occlusion of the lower limb, double-blind trials of a placebo, of tolazoline in a dose of 50 mg., and of thymoxamine in single doses of 20, 40, 60, 80, and 100 mg.